{"Symbol": "AMPH", "AssetType": "Common Stock", "Name": "Amphastar P", "Description": "Amphastar Pharmaceuticals, Inc., a specialty pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company is headquartered in Rancho Cucamonga, California.", "CIK": "1297184", "Exchange": "NASDAQ", "Currency": "USD", "Country": "USA", "Sector": "HEALTHCARE", "Industry": "DRUG MANUFACTURERS - SPECIALTY & GENERIC", "Address": "11570 6TH STREET, RANCHO CUCAMONGA, CA, UNITED STATES, 91730", "OfficialSite": "https://www.amphastar.com", "FiscalYearEnd": "December", "LatestQuarter": "2025-09-30", "MarketCapitalization": "1325110000", "EBITDA": "228831000", "PERatio": "12.61", "PEGRatio": "2.77", "BookValue": "16.76", "DividendPerShare": "None", "DividendYield": "None", "EPS": "2.26", "RevenuePerShareTTM": "15.3", "ProfitMargin": "0.154", "OperatingMarginTTM": "0.252", "ReturnOnAssetsTTM": "0.0674", "ReturnOnEquityTTM": "0.148", "RevenueTTM": "723305000", "GrossProfitTTM": "357035000", "DilutedEPSTTM": "2.26", "QuarterlyEarningsGrowthYOY": "-0.526", "QuarterlyRevenueGrowthYOY": "0.003", "AnalystTargetPrice": "31.57", "AnalystRatingStrongBuy": "1", "AnalystRatingBuy": "2", "AnalystRatingHold": "4", "AnalystRatingSell": "0", "AnalystRatingStrongSell": "0", "TrailingPE": "12.61", "ForwardPE": "-", "PriceToSalesRatioTTM": "1.832", "PriceToBookRatio": "1.688", "EVToRevenue": "2.339", "EVToEBITDA": "7.59", "Beta": "0.881", "52WeekHigh": "32.69", "52WeekLow": "20.39", "50DayMovingAverage": "27.03", "200DayMovingAverage": "25.84", "SharesOutstanding": "45952200", "SharesFloat": "34803700", "PercentInsiders": "24.296", "PercentInstitutions": "76.813", "DividendDate": "None", "ExDividendDate": "None"}